Načítá se...

Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)

INTRODUCTION: Anticoagulation without bleeding is an ideal goal in treating thrombosis, however, this goal has not been achieved. All current anticoagulants are associated with significant bleeding which limits their safe use. Genetic and pharmacological findings indicate that factor XIa is a key pl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Expert Opin Ther Pat
Hlavní autor: Al-Horani, Rami A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515655/
https://ncbi.nlm.nih.gov/pubmed/31847619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2020.1705783
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!